Comment on: GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region

Authors

Article Type

In Brief

First Page

954

Last Page

954

Recommended Citation

(2025) "Comment on: GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region," Saudi Medical Journal: Vol. 46: Iss. 8, Article 14.
DOI: https://doi.org/10.15537/smj.2025.46.20250193